{"id":"healthy-donor-stool","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal symptoms (abdominal pain, bloating, diarrhea)"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Infection or bacteremia (rare)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"FMT introduces a diverse community of commensal bacteria from a healthy donor into the patient's gastrointestinal tract, reestablishing a balanced microbiome. This restores microbial diversity, metabolic function, and competitive exclusion of pathogenic organisms, thereby improving intestinal barrier function and immune homeostasis. The mechanism is primarily ecological rather than targeting a single molecular pathway.","oneSentence":"Healthy donor stool restores the patient's gut microbiota composition and function through fecal microbiota transplantation (FMT).","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:15:02.170Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Clostridioides difficile infection (recurrent or refractory)"},{"name":"Inflammatory bowel disease (Crohn's disease or ulcerative colitis)"}]},"trialDetails":[{"nctId":"NCT06478602","phase":"PHASE3","title":"Implications of Fecal Microbiota Transplantation in Modulating the Effects of Liver Cirrhosis","status":"COMPLETED","sponsor":"Cristian Ichim","startDate":"2024-08-05","conditions":"Liver Cirrhosis","enrollment":19},{"nctId":"NCT03971669","phase":"PHASE4","title":"Blood Donor CVD 5000","status":"RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2004-01-16","conditions":"Risk Reduction","enrollment":150},{"nctId":"NCT07496502","phase":"PHASE1, PHASE2","title":"Effect of Oral Microbiota on MDRO Decolonization","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2022-03-31","conditions":"Clostridioides Difficile Infection, Drug Resistance, Bacterial, Gastrointestinal Microbiome","enrollment":42},{"nctId":"NCT07490054","phase":"PHASE1","title":"Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure","status":"RECRUITING","sponsor":"Melana Yuzefpolskaya, MD","startDate":"2025-09-01","conditions":"Chronic Heart Failure","enrollment":40},{"nctId":"NCT00090662","phase":"","title":"Collection of Data and Samples From Healthy Donors for Use in Translational Research","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2004-12-09","conditions":"Healthy Volunteer","enrollment":150},{"nctId":"NCT05669846","phase":"PHASE2","title":"Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC","status":"RECRUITING","sponsor":"Diwakar Davar","startDate":"2025-01-08","conditions":"Non Small Cell Lung Cancer","enrollment":26},{"nctId":"NCT06290258","phase":"PHASE1, PHASE2","title":"Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.","status":"RECRUITING","sponsor":"Chang Gung Memorial Hospital","startDate":"2024-03-06","conditions":"Autism Spectrum Disorder, Gastrointestinal Diseases, Healthy","enrollment":60},{"nctId":"NCT07486492","phase":"EARLY_PHASE1","title":"Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel Cancer","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Xiamen University","startDate":"2026-03-31","conditions":"Colorectal Cancer Metastatic, Fecal Microbiota Transplantation","enrollment":10},{"nctId":"NCT05174273","phase":"PHASE2, PHASE3","title":"Neurocognitive Effects of FMT in MDD Patients With and Without IBS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Valerie Taylor","startDate":"2022-04-06","conditions":"Major Depressive Disorder, Irritable Bowel Syndrome","enrollment":133},{"nctId":"NCT06071312","phase":"PHASE1, PHASE2","title":"FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2023-09-23","conditions":"Clostridium Difficile, Ulcerative Colitis","enrollment":64},{"nctId":"NCT05739825","phase":"","title":"Changes in Recipients Gut Microbiota After Fecal Microbiota Transplantation","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2023-02-13","conditions":"Clostridioides Difficile Infection Recurrence","enrollment":20},{"nctId":"NCT07477782","phase":"PHASE2","title":"Fecal Microbiota Transplantation for Primary Sclerosing Cholangitis - Randomized Study Versus Sham Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-05","conditions":"Primary Sclerosing Cholangitis (PSC), Inflammatory Bowel Disease (IBD)","enrollment":72},{"nctId":"NCT06214403","phase":"PHASE2","title":"Antimicrobial Resistant Organism Decolonization After Microbiome Perturbation","status":"WITHDRAWN","sponsor":"University Health Network, Toronto","startDate":"2026-07","conditions":"Gram-negative Bacteremia, Microbial Colonization, Antibiotic Resistant Infection","enrollment":""},{"nctId":"NCT07464392","phase":"NA","title":"FMT for the Prevention of Infectious Complications in Patients With Moderately Severe and Severe Acute Pancreatitis","status":"NOT_YET_RECRUITING","sponsor":"Changhai Hospital","startDate":"2026-03-01","conditions":"Acute Pancreatitis","enrollment":150},{"nctId":"NCT04373473","phase":"PHASE2","title":"Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-09-14","conditions":"Adults With Ulcerative Colitis","enrollment":58},{"nctId":"NCT07458984","phase":"PHASE3","title":"FMT Capsules for rCDI","status":"NOT_YET_RECRUITING","sponsor":"Helsinki University Central Hospital","startDate":"2026-02-25","conditions":"Clostridioides Difficile Infection Recurrence, FMT","enrollment":76},{"nctId":"NCT05917379","phase":"PHASE1, PHASE2","title":"The Efficacy and Safty of FMT in Patients With CID","status":"COMPLETED","sponsor":"Peking University Sixth Hospital","startDate":"2023-10-08","conditions":"Insomnia Chronic, Fecal Microbiota Transplantation, Sleep Disorder","enrollment":80},{"nctId":"NCT05740319","phase":"NA","title":"Efficacy and Safety Evaluation of Fecal Microbiota Transplantation in Irritable Bowel Syndrome","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2023-06-10","conditions":"Irritable Bowel Syndrome","enrollment":102},{"nctId":"NCT07421947","phase":"NA","title":"Effects of Fecal Microbiota Transplantation in Patients With Type 2 Diabetes and Coronary Artery Disease (CAD-Microbiome) - A Pilot Study","status":"NOT_YET_RECRUITING","sponsor":"University of Zurich","startDate":"2026-04","conditions":"Coronary Artery Disease, Type 2 Diabetes Mellitus (T2DM)","enrollment":30},{"nctId":"NCT07375797","phase":"NA","title":"Fecal Microbiota Transplantation Intervention on Microbiota Composition and Insulin Sensitivity in Diabetes","status":"RECRUITING","sponsor":"Central Jutland Regional Hospital","startDate":"2026-02-05","conditions":"Diabetes Mellitus Type 2, Fecal Microbiota Transplantation (FMT), Oral Glucose Tolerance Test","enrollment":16},{"nctId":"NCT06631586","phase":"PHASE2","title":"Standardized Microbiota Transplant Therapy in Crohn's Disease","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2025-01-15","conditions":"Crohn Disease","enrollment":120},{"nctId":"NCT06499896","phase":"PHASE2","title":"Healthy-donor Microbiome MTP-101-C in Steroid Relapse/Refractory Immune-related Cutaneous Adverse Events (irCAEs) and Immune-mediated Colitis (IMC)","status":"RECRUITING","sponsor":"Diwakar Davar","startDate":"2025-01-23","conditions":"Immune-mediated Colitis (IMC), Immune-related Dermatitis","enrollment":30},{"nctId":"NCT03686202","phase":"PHASE2, PHASE3","title":"Feasibility Study of MET-4: Evaluating Fecal Microbiome Effects in Immunotherapy Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2018-11-30","conditions":"All Solid Tumors","enrollment":65},{"nctId":"NCT07386795","phase":"NA","title":"The Efficacy and Safety of Microbiota Transplantation Combined With Prebiotics for Treatment of Functional Constipation","status":"NOT_YET_RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2026-02-01","conditions":"Constipation - Functional, Chronic Constipation, Fecal Microbiota Transplantation","enrollment":19},{"nctId":"NCT07017946","phase":"PHASE1, PHASE2","title":"Intestinal Microbiome Transplant in ALS","status":"RECRUITING","sponsor":"Duke University","startDate":"2026-01-27","conditions":"Amyotrophic Lateral Sclerosis ALS","enrollment":20},{"nctId":"NCT06649981","phase":"PHASE1","title":"Aging Resilience Through Microbiota Optimization and Regulation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gonzalo Jorquera, PhD","startDate":"2025-01-10","conditions":"Resilience, Cognitive Function and Well-Being, Muscle Function, Handgrip Strength Test","enrollment":80},{"nctId":"NCT07212400","phase":"","title":"Collection of Stool From Healthy Donors for the ex Vivo Study of Shifts of Microbiome Induced by Dairy Phages and Antibiotics: a Model of Bacteria/Host Interaction (DAIRY-SHAPE)","status":"RECRUITING","sponsor":"Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement","startDate":"2025-10-16","conditions":"General Population (no Specific Condition or Disease)","enrollment":4},{"nctId":"NCT03420482","phase":"PHASE2","title":"Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2018-04-01","conditions":"Hepatic Encephalopathy","enrollment":30},{"nctId":"NCT07275489","phase":"","title":"CHOICE KERGUELEN 2 : Consequences of Longterm Confinement on Immunity in the Sub-Antarctic Islands : Follow-up of Volunteers on the Kerguelen Islands","status":"RECRUITING","sponsor":"University Hospital, Angers","startDate":"2025-12-20","conditions":"Human Health in Extreme Conditions","enrollment":9},{"nctId":"NCT07065253","phase":"","title":"CHOICE KERGUELEN 1: Consequences of Longterm Confinement on Immunity in the Sub-Antarctic Islands: Inclusion of Volunteers Before Departure to the Kerguelen Islands","status":"COMPLETED","sponsor":"University Hospital, Angers","startDate":"2025-09-25","conditions":"Human Health in Extreme Conditions","enrollment":9},{"nctId":"NCT03819803","phase":"PHASE3","title":"Fecal Microbiota Transplantation in aGvHD After ASCT","status":"RECRUITING","sponsor":"Medical University of Graz","startDate":"2017-03-01","conditions":"Graft Versus Host Disease in GI Tract","enrollment":15},{"nctId":"NCT07240181","phase":"","title":"OPTImization of Inflammatory Bowel Disease Treatment Through Understanding of Gut VIRome Heterogeneity","status":"NOT_YET_RECRUITING","sponsor":"Andreas Munk Petersen","startDate":"2025-12-01","conditions":"IBD (Inflammatory Bowel Disease), Crohns Disease, Colitis Ulcerative","enrollment":40},{"nctId":"NCT05911997","phase":"PHASE1","title":"MTC Versus FMT in for RCDI","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2024-01-08","conditions":"Clostridiodies Difficile Infections","enrollment":60},{"nctId":"NCT06321536","phase":"PHASE2","title":"Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT)","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-01-13","conditions":"Multi-Drug Resistant Organism Colonization","enrollment":60},{"nctId":"NCT06481852","phase":"PHASE1","title":"A Placebo-controlled, Randomized Clinical Trial to Assess the Safety, Feasibility, and Pharmacokinetics of Microbiota Transplant Therapy With Antibiotic Preconditioning and Fiber Supplementation in Patients With Pulmonary Arterial Hypertension","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2024-10-28","conditions":"Pulmonary Arterial Hypertension","enrollment":24},{"nctId":"NCT04883762","phase":"PHASE1","title":"Stool Transplant to Control Treatment-related Diarrhea","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-05-10","conditions":"Fecal Microbiota Transplantation (FMT)","enrollment":4},{"nctId":"NCT07196410","phase":"PHASE1","title":"KAN-004 for Immune-Related Diarrhea or Colitis","status":"NOT_YET_RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2025-10-01","conditions":"Colitis, Diarrhea Caused by Antitumor Drugs","enrollment":21},{"nctId":"NCT06030037","phase":"PHASE2","title":"Pembrolizumab/Lenvatinib With and Without Healthy Donor FMT (hdFMT) in Relapsed/ Refractory (R/R) Melanoma","status":"WITHDRAWN","sponsor":"Diwakar Davar","startDate":"2025-03-11","conditions":"PD-1 Refractory Advanced Melanoma","enrollment":""},{"nctId":"NCT05266807","phase":"PHASE3","title":"Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence","status":"RECRUITING","sponsor":"Benoit Guery","startDate":"2023-03-15","conditions":"Clostridioides Difficile Infection","enrollment":220},{"nctId":"NCT04163289","phase":"PHASE1","title":"Preventing Toxicity in Renal Cancer Patients Treated With Immunotherapy Using Fecal Microbiota Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2020-01-23","conditions":"Renal Cell Carcinoma","enrollment":20},{"nctId":"NCT05753774","phase":"NA","title":"Effect of Fecal Microbiota Transplantation (FMT) in Pediatric Functional Gastrointestinal Disorders","status":"RECRUITING","sponsor":"Biao Zou","startDate":"2022-08-01","conditions":"Functional Gastrointestinal Disorders","enrollment":100},{"nctId":"NCT06022406","phase":"PHASE2","title":"Fecal Microbiota Translantation (FMT) to Reduce Inflammation in PLWH: The Gutsy Pilot Study","status":"COMPLETED","sponsor":"Jean-Pierre Routy","startDate":"2024-07-31","conditions":"HIV-1-infection","enrollment":20},{"nctId":"NCT06744751","phase":"NA","title":"A Study on the Effects of Combined FMT on Gut Microbiota and Eating Disorder Symptoms in AN","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Mental Health Center","startDate":"2025-09-01","conditions":"Anorexia Nervosa","enrollment":30},{"nctId":"NCT02694484","phase":"NA","title":"Search Cytomegalovirus in Healthy Volunteers Stools Samples Selected as Potential Donor for Fecal Microbiota Transplant","status":"COMPLETED","sponsor":"University Hospital, Limoges","startDate":"2016-06","conditions":"CMV, Healthy Volunteers","enrollment":500},{"nctId":"NCT05829109","phase":"EARLY_PHASE1","title":"Fecal Microbiota Transplant for Patients With Chronic Pouchitis","status":"RECRUITING","sponsor":"Maia Kayal","startDate":"2024-09-01","conditions":"Chronic Pouchitis, Pouchitis","enrollment":16},{"nctId":"NCT05834010","phase":"EARLY_PHASE1","title":"Feasibility Study of Using Fecal Microbiota Transplants in Anorexia Nervosa","status":"COMPLETED","sponsor":"Hvidovre University Hospital","startDate":"2023-03-18","conditions":"Anorexia Nervosa, Microbiome Dysbiosis","enrollment":17},{"nctId":"NCT06687382","phase":"PHASE2","title":"Clinical Trial With MBK-01, Intestinal Microbiota Capsules, for the Treatment of Patients With Recurrent Diverticulitis","status":"RECRUITING","sponsor":"Mikrobiomik Healthcare Company S.L.","startDate":"2025-04-03","conditions":"Diverticulitis, Diverticulitis of Sigmoid","enrollment":81},{"nctId":"NCT05035342","phase":"PHASE3","title":"Fecal Transplantation to Eradicate Colonizing Emergent Superbugs","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-01-11","conditions":"Enterobacteriaceae Infections, Fecal Microbiota Transplantation","enrollment":214},{"nctId":"NCT05548452","phase":"PHASE1, PHASE2","title":"Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease","status":"RECRUITING","sponsor":"Virginia Commonwealth University","startDate":"2022-11-21","conditions":"Liver Disease; Alcohol-Related, Cirrhosis, Alcohol Use Disorder","enrollment":80},{"nctId":"NCT05204641","phase":"PHASE2","title":"Effect of Fecal Microbiota Transfer on Progression of Parkinson Disease","status":"COMPLETED","sponsor":"Medical University of Warsaw","startDate":"2022-01-04","conditions":"Parkinson Disease","enrollment":59},{"nctId":"NCT02970877","phase":"PHASE2","title":"Stool Transplantation for Treatment of Insulin Resistance in Morbidly Obese Patients","status":"COMPLETED","sponsor":"Johane Allard","startDate":"2017-03-01","conditions":"Obesity, Morbid, Insulin Resistance","enrollment":29},{"nctId":"NCT05202990","phase":"PHASE2","title":"Oral Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-07-01","conditions":"Pediatric Ulcerative Colitis in Remission","enrollment":26},{"nctId":"NCT06388863","phase":"NA","title":"Evaluation of the Efficacy and Safety of Fecal Microbiota Transplantation for Constipation in Parkinson's Disease","status":"RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2025-02-21","conditions":"Parkinson Disease","enrollment":76},{"nctId":"NCT03838601","phase":"NA","title":"Role of Microbiome as a Biomarkers in Locoregionally-Advanced Oropharyngeal Squamous Cell Carcinoma 2","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2019-07-02","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":30},{"nctId":"NCT05201079","phase":"PHASE3","title":"Primary or Recurrent Clostridioides Difficile Infection Treatment With Capsules of Lyophilised Faecal Microbiota vs Fidaxomicin","status":"COMPLETED","sponsor":"Mikrobiomik Healthcare Company S.L.","startDate":"2021-10-29","conditions":"Recurrent Clostridium Difficile Infection, Primary Clostridium Difficile Infection","enrollment":93},{"nctId":"NCT05803980","phase":"NA","title":"Fecal Microbiota Transplantation to Relieve Symptoms of Irritable Bowel Syndrome Without Constipation","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-12-23","conditions":"Irritable Bowel Syndrome","enrollment":35},{"nctId":"NCT05182775","phase":"NA","title":"A Clinical Research on the Use of Fecal Bacteria Transplantation for Treatment of IgA Nephropathy","status":"COMPLETED","sponsor":"Shanxi Provincial People's Hospital","startDate":"2022-01-01","conditions":"IgA Nephropathy","enrollment":15},{"nctId":"NCT05803993","phase":"NA","title":"Fecal Microbiota Transplantation to Relieve Symptoms of Irritable Bowel Syndrome With Constipation","status":"RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-12-23","conditions":"Irritable Bowel Syndrome","enrollment":35},{"nctId":"NCT06192693","phase":"PHASE3","title":"Fecal Microbiota Transfer to Improve Diabetes Control Post-bariatric Surgery","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-01-21","conditions":"Bariatric Surgery, Type 2 Diabetes","enrollment":54},{"nctId":"NCT04932577","phase":"PHASE2, PHASE3","title":"Faecal Microbiota Transplantation for Liver Cirrhosis","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2021-07-01","conditions":"Liver Cirrhosis","enrollment":220},{"nctId":"NCT05006430","phase":"PHASE1, PHASE2","title":"Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis","status":"RECRUITING","sponsor":"Prasun Kumar Jalal","startDate":"2023-01-21","conditions":"Alcoholic Hepatitis","enrollment":50},{"nctId":"NCT06393400","phase":"PHASE1","title":"CHemotherapy and Stool Transplant in PDAC (CHASe-PDAC)","status":"RECRUITING","sponsor":"John Lenehan","startDate":"2025-01-08","conditions":"Unresectable or Metastatic Advanced Pancreatic Ductal Adenocarcinoma","enrollment":20},{"nctId":"NCT04749030","phase":"NA","title":"Faecal Microbiota Transplantation for Patients With Diabetes Mellitus Type 1 and Severe Gastrointestinal Neuropathy","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2021-06-15","conditions":"Faecal Microbiota Transplantation (FMT), Diabetes Mellitus, Type 1, Gastrointestinal Neuropathy","enrollment":20},{"nctId":"NCT06593366","phase":"NA","title":"Fecal Microbiota Transplant for Anorexia Nervosa","status":"NOT_YET_RECRUITING","sponsor":"McMaster University","startDate":"2025-01-01","conditions":"Anorexia Nervosa Restricting Type, Anorexia Nervosa, Anorexia in Adolescence","enrollment":20},{"nctId":"NCT03545386","phase":"PHASE2","title":"Fecal Microbiota Transplantation for Pouchitis","status":"RECRUITING","sponsor":"McMaster University","startDate":"2019-04-17","conditions":"Pouchitis","enrollment":34},{"nctId":"NCT05321745","phase":"NA","title":"Fecal Microbiota Transplantation in Pediatric Crohn's Disease","status":"RECRUITING","sponsor":"Biao Zou","startDate":"2022-03-22","conditions":"Crohn Disease","enrollment":40},{"nctId":"NCT06643533","phase":"","title":"Fecal Microbiota Transplantation in Reversing Drug Resistance in Unresectable HCC (TALENP004)","status":"NOT_YET_RECRUITING","sponsor":"Fujian Provincial Hospital","startDate":"2025-01-01","conditions":"Hepatocellular Carcinoma Non-resectable","enrollment":15},{"nctId":"NCT04854291","phase":"NA","title":"A Trial of Fecal Microbiome Transplantation in Parkinson's Disease Patients","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2021-04-25","conditions":"Parkinson Disease","enrollment":51},{"nctId":"NCT04926103","phase":"NA","title":"Screening Donors, Fecal Microbiota Transplant Program in Ulcerative Colitis","status":"RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2022-07-01","conditions":"Ulcerative Colitis Flare","enrollment":200},{"nctId":"NCT06503978","phase":"PHASE2","title":"Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gut-Brain-Axis Therapeutics Inc.","startDate":"2024-08-20","conditions":"Autism Spectrum Disorder, Gastro-Intestinal Disorder, Constipation","enrollment":60},{"nctId":"NCT04188743","phase":"PHASE2, PHASE3","title":"Decolonization of Gram-negative Multi-resistant Organisms (MDRO) with Donor Microbiota (FMT)","status":"RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2019-12-18","conditions":"Resistance Bacterial","enrollment":150},{"nctId":"NCT03796650","phase":"PHASE3","title":"Fecal Transplantation for Primary Clostridium Difficile Infection","status":"TERMINATED","sponsor":"Oslo University Hospital","startDate":"2019-07-17","conditions":"Clostridium Difficile Infection","enrollment":104},{"nctId":"NCT03766321","phase":"NA","title":"Fecal Microbiota Transplantation Effect on Amyotrophic Lateral Sclerosis Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Azienda Ospedaliero-Universitaria di Modena","startDate":"2020-07-01","conditions":"Amyotrophic Lateral Sclerosis","enrollment":42},{"nctId":"NCT06478823","phase":"NA","title":"Healthy Stool Volunteer Donors for Fecal Microbiota Transplantation Trials","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-07-08","conditions":"Gastro-Intestinal Disorder","enrollment":400},{"nctId":"NCT06205862","phase":"PHASE2","title":"Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Reducing Recurrence of Colorectal Adenoma (CRA)","status":"RECRUITING","sponsor":"Shenzhen Hospital of Southern Medical University","startDate":"2024-04-09","conditions":"Fecal Microbiota Transplantation, Colorectal Adenoma, Gastrointestinal Microbiome","enrollment":466},{"nctId":"NCT06478498","phase":"NA","title":"Immune Responses in the Skin After Hookworm Infection","status":"NOT_YET_RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2024-10-01","conditions":"Necator Americanus Infection","enrollment":5},{"nctId":"NCT06466707","phase":"NA","title":"Collection of Microbiome Samples of Healthy Western Donors for Fundamental and Functional Microbiome Research","status":"RECRUITING","sponsor":"University Ghent","startDate":"2024-06-04","conditions":"Microbial Colonization","enrollment":100},{"nctId":"NCT04201821","phase":"PHASE1, PHASE2","title":"Fecal Microbial Transplantation for the Treatment of Fecal Incontinence in Women","status":"TERMINATED","sponsor":"University of Pennsylvania","startDate":"2021-01-14","conditions":"Fecal Incontinence","enrollment":10},{"nctId":"NCT06451588","phase":"PHASE2","title":"Fecal Microbiota Transplantation in Axial Spondyloarthritis","status":"RECRUITING","sponsor":"University Hospital of North Norway","startDate":"2024-06-01","conditions":"Axial Spondyloarthritis, Ankylosing Spondylitis, Dysbiosis","enrollment":99},{"nctId":"NCT05272566","phase":"","title":"Prephage - Faecal Bacteriophage Transfer for Enhanced Gastrointestinal Tract Maturation in Preterm Infants - Donor Study","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2022-04-01","conditions":"Feeding Patterns, Microbial Colonization","enrollment":38},{"nctId":"NCT04899869","phase":"NA","title":"Faecal Microbiota Transplantation in Irritable Bowel Syndrome","status":"COMPLETED","sponsor":"Thomayer University Hospital","startDate":"2021-06-17","conditions":"Irritable Bowel Syndrome With Diarrhea, Irritable Bowel Syndrome Mixed","enrollment":61},{"nctId":"NCT06424041","phase":"PHASE2","title":"Fecal Microbiome Transplantation From Healthy Donors to Individuals With Fibromyalgia","status":"ENROLLING_BY_INVITATION","sponsor":"Rambam Health Care Campus","startDate":"2024-03-11","conditions":"Fibromyalgia","enrollment":100},{"nctId":"NCT04371653","phase":"PHASE2","title":"A Prospective, Randomized, Placebo-Controlled Pilot Study to Characterize the Intestinal Microbiome and to Evaluate the Safety and Fecal Microbiome Changes Following Administration of Lyophilized PRIM-DJ2727 or Placebo Given Orally in Subjects With Nonalcoholic Fatty Liver Disease","status":"WITHDRAWN","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2023-12-01","conditions":"Nonalcoholic Fatty Liver Disease (NAFLD) With History of Diabetes Melitus","enrollment":""},{"nctId":"NCT01790061","phase":"PHASE2, PHASE3","title":"Standardized Fecal Microbiota Transplantation for Ulcerative Colitis","status":"RECRUITING","sponsor":"The Second Hospital of Nanjing Medical University","startDate":"2013-02","conditions":"Bacteria, Microbiota, Fecal Microbiota Transplantation","enrollment":500},{"nctId":"NCT06254625","phase":"PHASE1","title":"Fecal Transplantation in Patients Colonic Diverticulitis","status":"NOT_YET_RECRUITING","sponsor":"Odense University Hospital","startDate":"2024-04-01","conditions":"Diverticulitis, Colonic, Colon Inflamed","enrollment":40},{"nctId":"NCT05780801","phase":"PHASE1","title":"Sentinel Cohort REACT","status":"COMPLETED","sponsor":"Emory University","startDate":"2023-04-24","conditions":"Multi-Drug Resistant Organism","enrollment":10},{"nctId":"NCT06333405","phase":"NA","title":"Fecal Microbiota Transplantation (FMT) as a Prophylaxis of Necrotizing Enterocolitis (NEC) - Clinical Study","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2024-05-01","conditions":"Necrotizing Enterocolitis","enrollment":20},{"nctId":"NCT06321796","phase":"PHASE2","title":"Microbiota Transfer Therapy for Children and Adults With Both Pitt Hopkins Syndrome and Gastrointestinal Disorders","status":"RECRUITING","sponsor":"Gut-Brain-Axis Therapeutics Inc.","startDate":"2024-02-27","conditions":"Pitt Hopkins Syndrome","enrollment":20},{"nctId":"NCT02862249","phase":"PHASE3","title":"Trial of Faecal Microbiota Transplantation in Cirrhosis","status":"COMPLETED","sponsor":"King's College London","startDate":"2018-03-27","conditions":"Cirrhosis of the Liver","enrollment":32},{"nctId":"NCT03895593","phase":"","title":"Rescue Fecal Microbiota Transplantation for National Refractory Intestinal Infections","status":"RECRUITING","sponsor":"The Second Hospital of Nanjing Medical University","startDate":"2015-09-25","conditions":"Intestinal Infection, Clostridioides Difficile Infection, Antibiotic-associated Diarrhea","enrollment":100},{"nctId":"NCT06282952","phase":"NA","title":"NEwborn Infant of a Mother With Obesity - Fecal Microbiome Transplantation, RCT","status":"NOT_YET_RECRUITING","sponsor":"Oulu University Hospital","startDate":"2024-04-01","conditions":"Fecal Microbiota Transplantation, Cesarean Section, Overweight and Obesity","enrollment":150},{"nctId":"NCT04884971","phase":"PHASE1","title":"Microbiota Transplant Therapy for Pulmonary Arterial Hypertension: Early Safety and Feasibility Study","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2021-11-03","conditions":"Pulmonary Arterial Hypertension","enrollment":11},{"nctId":"NCT05703477","phase":"NA","title":"The Dynamic Fluctuation of Donor Microbiota Affects the Prognosis of Fecal Microbiota Transplantation for C. Difficile Infection","status":"COMPLETED","sponsor":"Shanghai 10th People's Hospital","startDate":"2020-01-01","conditions":"Clostridium Difficile Infection, Fecal Microbiota Transplantation","enrollment":60},{"nctId":"NCT04203017","phase":"PHASE1","title":"Fecal Microbiota Transplantation After Autologous HSCT in Patients With Multiple Sclerosis","status":"TERMINATED","sponsor":"St. Petersburg State Pavlov Medical University","startDate":"2019-06-01","conditions":"Multiple Sclerosis","enrollment":20},{"nctId":"NCT06156956","phase":"NA","title":"Fecal Microbiota Transplantation (FMT) to Decolonize Antibiotic - Resistant Bacteria (ARB) - New Protocol","status":"UNKNOWN","sponsor":"Human Biome Institute S.A.","startDate":"2023-10-27","conditions":"Drug Resistance, Bacterial, Antimicrobial Drug Resistance","enrollment":200},{"nctId":"NCT02291523","phase":"PHASE1","title":"The Effect of Therapeutic Fecal Transplant on the Gut Microbiome in Children With Ulcerative Colitis","status":"UNKNOWN","sponsor":"Children's Hospital Los Angeles","startDate":"2016-11-01","conditions":"Ulcerative Colitis","enrollment":101},{"nctId":"NCT03426826","phase":"PHASE1","title":"The Gut-Brain Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Hospital Los Angeles","startDate":"2019-08-15","conditions":"Autism Spectrum Disorder (ASD), Gastro-Intestinal Disorder","enrollment":10},{"nctId":"NCT02330653","phase":"PHASE1, PHASE2","title":"Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's Colitis","status":"COMPLETED","sponsor":"Stacy A. Kahn","startDate":"2015-11","conditions":"Inflammatory Bowel Diseases, Ulcerative Colitis, Crohn Disease","enrollment":15},{"nctId":"NCT04155099","phase":"PHASE2","title":"Investigational Microbiota Restoration Therapeutic for Hepatic Encephalopathy","status":"TERMINATED","sponsor":"Ochsner Health System","startDate":"2021-03-01","conditions":"Hepatic Encephalopathy, Cirrhosis, Liver","enrollment":5},{"nctId":"NCT04236843","phase":"NA","title":"Faecal Microbiota Transplantation (FMT) in Patients With IBSmechanism(s) of Action","status":"COMPLETED","sponsor":"Helse Fonna","startDate":"2020-02-03","conditions":"Irritable Bowel Syndrome","enrollment":186}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":15,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Fecal microbiota transplantation","FMT"],"phase":"phase_3","status":"active","brandName":"Healthy donor stool","genericName":"Healthy donor stool","companyName":"Helsinki University Central Hospital","companyId":"helsinki-university-central-hospital","modality":"Biologic","firstApprovalDate":"","aiSummary":"Healthy donor stool restores the patient's gut microbiota composition and function through fecal microbiota transplantation (FMT). Used for Clostridioides difficile infection (recurrent or refractory), Inflammatory bowel disease (Crohn's disease or ulcerative colitis).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}